Welcome to the 4th International Seminar in Engineering, Health and
21 – 22 JUNE 2023, ALGIERS – ALGERIA
Welcome to the 4th International Seminar in Engineering, Health and Analysis: Pharmaceutical Process – SEHA -2023
The pharmaceutical sector is directly impacted by research. The drugs being developed based on discoveries from fundamental or applied sciences research. By the use of more efficient manufacturing methods, the pharmaceutical landscape has experienced a major upheaval. These researches have substantially aided drug development, allowing the process to become more precise.
Pharmaceutical process team (LPDT) from the Faculty of Mechanical and Process engineering, USTHB, organize the 4th International Seminar in Engineering, Health and Analysis: Pharmaceutical Process in Algiers, Algeria on 21st and 22 June, 2023.
For this fourth edition, the seminar is placed under the slogan: Pharmaceutical engineering, the heart of health product development. Its ambition is to present the best research works in the field of pharmaceutical engineering assisting in the development of health products.
This event has been initiated to facilitate beneficial exchanges between all parties involved in the field of pharmaceutical technology and to provide an excellent opportunity for the development and deepening of scientific cooperation among academics, practitioners, and business professionals.
Such occasion can create an additional possibility for attendees to discuss their results, the new developments and the future directions. The conference day could also promote scientific exchanges for talented young researchers in pharmaceutical departments of different universities and academic workplaces throughout the country.
The main topics of the conference include, but are not limited to:
Drug synthesis and extraction process: medicinal plants, chemical synthesis , biotechnology...1
Medicines conception process: Pre formulation and formulation studies, stability, simulation …3
Medicinal devices manufacturing process: masks, bandages, sticking plaster…5
Purification process and analytical methods: crystallization…2
Utilities: production of water and medical gas, air and effluent treatment4
Manufacturing process of food supplements6
Manufacturing process of cosmetic products7
َAmong our Speakers :
Université de Genève
Eric Allémann was born in 1963. He studied pharmacy at the University of Geneva. From 1990 to 1993, he worked on his thesis in the field of parenteral polymeric drug delivery systems with extended release properties. He obtained his Ph.D. in 1993. He went then to the Faculty of Medicine of the University of Sherbrooke (Quebec) for a post-doc. In 1995, he became research associate and lecturer at the University of Geneva. In 1997, the Swiss Confederation for the renewal of academic positions appointed him. He obtained in October 1999 a position of “maître d'enseignement et de recherche”. Since October 2001, he joined the Geneva research center of the pharmaceutical company Bracco Group, as senior research scientist. He was involved in therapeutic and diagnostic nanomedicines. In 2004, he was appointed Manager and was heading the Department of Novel Agents Research at Bracco Research Geneva. In 2009 he became full professor of Pharmaceutical technology at the Geneva-Lausanne School of Pharmacy (EPGL), located at the University of Geneva. Since July 2018, he was elected President of the School of pharmaceutical sciences. Eric Allémann's research interests are focused on the delivery of active substances by means of supramolecular constructs, nano- and microparticles for the controlled release and drug targeting as well as for contrast agents for various medical imaging techniques.
He is (co)-inventor for 15 international patents and has authored and co-authored more than 100 research and review articles.
Additionally to his academic duties, Eric is co-founder of KYLYS a start-up company developing biopolymers
University of Navarra
Juan M. IRACHE is Professor of Pharmaceutical Technology at the University of Navarra. He was a postdoctoral fellow at the Department of Galenics in the University of Paris South (1992-1993) and Associate Professor (Maître de Conférences Universitaire) at the University of Rouen in France (1993-1996). His research is focused on the design and evaluation of nanocarriers (e.g., polymer nanoparticles, SNEDDS, protein nanodevices) for (i) the delivery of drugs, actives and biomacromolecules through biological barriers, and (ii) the development of new mucosal adjuvants for vaccination and immunotherapy.
University of Szeged
Name: Dr. Krisztina Ludasi
PhD degree, University of Szeged, 2021
Quality Assurance Pharmacist, University of Szeged, 2020
Masters degree in Pharmacy, University of Albert Szent-Györgyi, 1996
Assistant lecturer, University of Szeged, Institute of Pharmaceutical Technology and Regulatory Affairs, since 2019
PhD student, University of Szeged, Institute of Pharmaceutical Technology and Regulatory Affairs, 2016-2019
QA pharmacist, ExtractumPharma Zrt, 2015
Key account manager, sales representative at ExtractumPharma Zrt., Lilly Hungária Kft., Sanofi-Aventis Zrt., Aventis, Hoechst Marion Roussel Pharmaceutical companies, 1997-2015
Pharmaceutical sales representative, Pharmafontana Pharmaceutical Rt., 1996-1997
Field of Research:
Development of anti-counterfeiting drug identification technologies using laser technology
Film coating of solid pharmaceutical dosage forms.
CINaM-CNRS, Aix-Marseille University
Stéphane Veesler is an academic researcher from Aix-Marseille University. The author has contributed to research in topic(s): Crystallization & Nucleation. The author has an hindex of 34, co-authored 119 publication(s) receiving 3251 citation(s). Previous affiliations of Stéphane Veesler include Centre national de la recherche scientifique & University of California, Santa Barbara.
Université de Sherbrooke
Titulaire de la Chaire de Recherche du Canada en intensification des procédés pour catalyseurs avancés et énergie durable
Intensification des procédés chimiques et pharmaceutiques; Efficacité énergétique; Catalyseurs hétérogènes, Procédé assisté par plasma froid; Conversion catalytique.
University of Blida
Abdelkader Hadj Sadok was born in Khémis Meliana in 1964. He earned his bachelor's degree in physics from Houari Boumediene University of Science and Technology (USTHB) in 1987. He began working as a teacher/researcher at the University of Blida in 1988. He obtained a master's degree in fluid mechanics at the USTHB in 1993. He then worked on his thesis named " Etude rhéologique et physicochimique des systèmes à structure complexe à base de caséinate de sodium" and received his Ph.D. from the University of Blida in 2009. In June 2014, he was granted the ability to conduct research. He has been a Professor since July 2019. He has more than 30 scientific research articles, with over 400 citations.
Pr. Hadj Sadok has also served as a consultant at CRD Saidal (1994-2010), Biopharm since 2007, and Venus, Wanylab, SARL Alger Chimie, and laboratoires Groupe Santé since 2017, 2018, 2020, and 2021, respectively.
SEHA – 2023
Papers submission deadline : 30/01/2023
Acceptance notifications : 01/03/2023
SEHA 2023 : 21-22 June 2023
The 4th International Seminar in Engineering, Health and Analysis: Pharmaceutical Process – SEHA -2023 will take place on 21 & 22 June 2023.